Natera president gifts 945 shares to charity

Q: How many Natera (NTRA) shares did Solomon Moshkevich gift?

Solomon Moshkevich gifted 945 shares of Natera Common Stock. The transaction was coded as a bona fide gift and the related footnote specifies that it represents a charitable contribution by the reporting person.

Q: Was the Natera (NTRA) insider gift made under a Rule 10b5-1 trading plan?

No. The filing indicates that the Rule 10b5-1 checkbox is not affirmed, and there is no footnote stating that the transaction was made pursuant to a Rule 10b5-1 or other pre-arranged trading plan.

Q: Did Solomon Moshkevich sell any Natera (NTRA) shares in this Form 4?

No. The Form 4 reports only a bona fide gift of 945 shares with a per-share price of $0.00; no open-market or other sales are reported in this filing.

Natera’s clinical diagnostics president donated 945 shares as a charitable gift and continues to hold over one hundred thousand shares.

Available on EDGAR 09/18/2026 - 09:36 PM EDT Accepted by SEC EDGAR 09/18/2026 - 09:35 PM EDT

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Natera, Inc. (NTRA) reported that Solomon Moshkevich, President, Clinical Diagnostics, made a bona fide gift of 945 shares of Common Stock on September 16, 2026 as a charitable contribution. Following this disposition, he directly holds 109,914 shares of Natera common stock, and no Rule 10b5-1 plan is reported.

Insider Trade Summary

945 shares gifted

Gift 1 txn

Insider Moshkevich Solomon

Role PRESIDENT, CLINICALDIAGNOSTICS

Type	Security	Shares	Price	Value
Gift	Common Stock ^F1	945	$0.00	$0.00

Holdings After Transaction: Common Stock — 109,914 shares (Direct)

Footnotes (1)

F1. Represents a charitable contribution by the Reporting Person.

Key Figures

Shares gifted: 945 shares Price per share: $0.00 per share Shares held after transaction: 109,914 shares +1 more

4 metrics

Shares gifted 945 shares Bona fide gift of Common Stock on September 16, 2026

Price per share $0.00 per share Reported for the 945-share bona fide gift

Shares held after transaction 109,914 shares Direct ownership by Solomon Moshkevich following the gift

Number of gift transactions 1 transaction Bona fide gift reported in this Form 4

Key Terms

bona fide gift, Common Stock, charitable contribution

3 terms

bona fide gift financial

"The transaction is described as a bona fide gift of 945 shares"

A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.

Common Stock financial

"The security involved is Natera, Inc. Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

charitable contribution financial

"Footnote states it represents a charitable contribution by the Reporting Person"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Natera (NTRA) disclose for Solomon Moshkevich?

Natera disclosed that President, Clinical Diagnostics, Solomon Moshkevich made a bona fide gift of 945 shares of Natera Common Stock on September 16, 2026 as a charitable contribution, with no cash consideration reported.

How many Natera (NTRA) shares did Solomon Moshkevich gift?

Solomon Moshkevich gifted 945 shares of Natera Common Stock. The transaction was coded as a bona fide gift and the related footnote specifies that it represents a charitable contribution by the reporting person.

What are Solomon Moshkevich’s Natera (NTRA) holdings after the reported gift?

After the charitable gift of 945 shares, Solomon Moshkevich directly holds 109,914 shares of Natera Common Stock. This post-transaction figure is disclosed as his total direct ownership following the transaction.

Was the Natera (NTRA) insider gift made under a Rule 10b5-1 trading plan?

No. The filing indicates that the Rule 10b5-1 checkbox is not affirmed, and there is no footnote stating that the transaction was made pursuant to a Rule 10b5-1 or other pre-arranged trading plan.

Did Solomon Moshkevich sell any Natera (NTRA) shares in this Form 4?

No. The Form 4 reports only a bona fide gift of 945 shares with a per-share price of $0.00; no open-market or other sales are reported in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Moshkevich Solomon

(Last)

(First)

(Middle)

C/O NATERA, INC.

13011 MCCALLEN PASS BUILDING A SUITE 100

(Street)

AUSTIN

TEXAS

78753

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Natera, Inc. [ NTRA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	PRESIDENT, CLINICALDIAGNOSTICS

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	09/16/2026		G		945⁽¹⁾	D	$0	109,914	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents a charitable contribution by the Reporting Person.

	/s/ Tami Chen, Attorney-in-Fact	09/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR